Concepedia

Christina Hartl

CH

Statistics

Publications

10

Citations

1.8K

H-Index

10

Active since

2012

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Dana-Farber/Harvard Cancer Center

Medical University of South Carolina

Christina Hartl is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

2012–2020

10

Publications

10

A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis

Elvin Wagenblast, Mar Soto, Sara Gutiérrez-Ángel et al. · Nature · 2015 · 459 citations · Full text

, , +10

T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity

Daniela Schmid, Chun Gwon Park, Christina Hartl et al. · Nature Communications · 2017 · 441 citations · Full text

, , +17

Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases

Chun Gwon Park, Christina Hartl, Daniela Schmid et al. · Science Translational Medicine · 2018 · 323 citations

, , +10

Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer

Anita K. Mehta, Emily Cheney, Christina Hartl et al. · Nature Cancer · 2020 · 259 citations · Full text

, , +16

The Immune Microenvironment in Hormone Receptor–Positive Breast Cancer Before and After Preoperative Chemotherapy

Adrienne G. Waks, Daniel G. Stover, Jennifer L. Guerriero et al. · Clinical Cancer Research · 2019 · 116 citations · Full text

, , +17

1–5 of 10